| Date | Title | Description | Source |
| 08.04.2024 | XORTX Announces Participation in Spring 2024 Investor Confer... | CALGARY, Alberta, April 08, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or t... | einpresswi... |
| 08.04.2024 | XORTX Welcomes New Member to the Board of Directors | CALGARY, Alberta, April 08, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or t... | einpresswi... |
| 19.03.2024 | XORTX: A Year of Milestones and Strategic Advancements as it... | In the realm of pharmaceutical innovation, XORTX Therapeutics Inc. (NAS: XRTX) on path or Clincial T... | einpresswi... |
| 15.02.2024 | XORTX Raises $2.5 Million Under Prospectus Supplement and Co... | - | globenewsw... |
| 15.01.2024 | XORTX Announces $2 Million Public Offering | NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES
OR FOR DISSEMINATION IN THE UNITED STATES
C... | einpresswi... |
| 10.11.2023 | XORTX Clarifies Timing for Share Consolidation | CALGARY, Alberta, Nov. 10, 2023 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or th... | einpresswi... |
| 24.06.2023 | XORTX Reminds Shareholders to Vote ahead of the Proxy Voting... | /EIN News/ -- The proxy voting deadline for XORTX shareholders to vote their proxies is 10:00 a.m. (... | einpresswi... |
| 01.02.2023 | XORTX Announces Submission of Orphan Drug Designation Reques... | /EIN News/ -- CALGARY, Alberta, Feb. 01, 2023 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XOR... | einpresswi... |
| 08.12.2022 | XORTX Announces New Proof of Concept Data in Autosomal Domin... | Independent Study Shows Moderate Dose Strength of XORLO™ Attenuates Kidney Expansion
/EIN News/ -- C... | einpresswi... |
| 28.11.2022 | XORTX Announces Completion of Screening and Enrollment in Br... | XRX-OXY-101 Study will inform the dose choice in the upcoming Phase 3 Clinical Trial
/EIN News/ -- C... | einpresswi... |
| 26.10.2022 | XORTX Receives Further No Objection Letter from Health Canad... | CALGARY, Alberta, Oct. 26, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or th... | globenewsw... |
| 25.10.2022 | XORTX Sponsored American Society of Nephrology Study Abstrac... | • Chronically Increased Uric Acid Accelerates Structural
and Functional Changes in Polycystic Kidney... | globenewsw... |
| 07.10.2022 | XORTX Announces Closing of US$5 Million Public Offering | CALGARY, Alberta, Oct. 07, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or th... | globenewsw... |
| 07.10.2022 | XORTX Announces Closing of US$5 Million Public Offering | /EIN News/ -- CALGARY, Alberta, Oct. 07, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XOR... | einpresswi... |
| 04.10.2022 | XORTX Announces US$5 Million Public Offering | CALGARY, Alberta, Oct. 04, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or th... | globenewsw... |
| 04.10.2022 | XORTX Announces US$5 Million Public Offering | /EIN News/ -- CALGARY, Alberta, Oct. 04, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XOR... | einpresswi... |
| 19.09.2022 | XORTX Completes Positive Pre-Phase 3 Meeting with the US Foo... | CALGARY, Alberta, Sept. 19, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or t... | globenewsw... |
| 01.09.2022 | XORTX Sponsored Study Selected for Presentation at the Ameri... | CALGARY, Alberta, Sept. 01, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or t... | globenewsw... |
| 22.08.2022 | XORTX Announces Positive Topline Results from Part 2 Pharmac... | CALGARY, Alberta, Aug. 22, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or th... | globenewsw... |
| 04.08.2022 | XORTX Announces Pre-Phase 3 Meeting Date with US Food and Dr... | CALGARY, Alberta, Aug. 04, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or th... | globenewsw... |
| 22.07.2022 | XORTX Reports Annual & Special Meeting Results | CALGARY, Alberta, July 22, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or th... | globenewsw... |
| 19.07.2022 | XORTX Announces Submission to European Medicines Agency | CALGARY, Alberta, July 19, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or th... | globenewsw... |
| 07.07.2022 | XORTX Announces Pre-Phase 3 Meeting Request with US Food and... | CALGARY, Alberta, July 07, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or th... | globenewsw... |
| 21.06.2022 | XORTX Announces “Fireside Chat” with XORTX CEO | CALGARY, Alberta, June 21, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or th... | globenewsw... |
| 13.06.2022 | XORTX to Present at BIO International Convention 2022 | CALGARY, Alberta, June 13, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or th... | globenewsw... |
| 06.06.2022 | XORTX Welcomes New Member to the Board of Directors and Appo... | CALGARY, Alberta, June 06, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or th... | globenewsw... |
| 25.05.2022 | XORTX to Present at H. C. Wainwright Global Investment Confe... | CALGARY, Alberta, May 25, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the... | globenewsw... |
| 05.05.2022 | XORTX Opens an IND for XRx-008 Program for Autosomal Dominan... | ● FDA Provides All Clear Notification for IND and Bridging Pharmacokinetics Study ●
CALGARY, Alberta... | globenewsw... |
| 03.05.2022 | XORTX Initiates Dosing of Human Subjects in the XRX-OXY-101 ... | CALGARY, Alberta, May 03, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the... | globenewsw... |
| 20.04.2022 | XORTX Receives Small and Medium Enterprise Status for the Eu... | CALGARY, Alberta, April 20, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or t... | globenewsw... |
| 12.04.2022 | XORTX Receives No Objection Letter from Health Canada | CALGARY, Alberta, April 12, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or t... | globenewsw... |
| 07.04.2022 | XORTX Announces Grant of US Patent | CALGARY, Alberta, April 07, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or t... | globenewsw... |
| 31.03.2022 | XORTX Files IND with US FDA | ● Autosomal Dominant Polycystic Kidney Disease – XRx-008 Program IND Filed ●
CALGARY, Alberta, March... | globenewsw... |
| 23.03.2022 | XORTX Files New PCT Patent to Treat and Protect Individuals ... | CALGARY, Alberta, March 23, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or t... | globenewsw... |
| 31.01.2022 | XORTX Provides Corporate Update | CALGARY, Alberta, Jan. 31, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or th... | globenewsw... |
| 20.01.2022 | XORTX Announces Appointment of Chief Technology Officer | CALGARY, Alberta, Jan. 20, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or th... | globenewsw... |
| 10.01.2022 | XORTX to Participate in H.C. Wainwright BioConnect 2022 Virt... | CALGARY, Alberta, Jan. 10, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or th... | globenewsw... |
| 21.12.2021 | XORTX Reports Annual & Special Meeting Results | CALGARY, Alberta, Dec. 21, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or th... | globenewsw... |
| 21.12.2021 | XORTX Therapeutics Announces Filing of Provision Patent for ... | CALGARY, Alberta, Dec. 21, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or th... | globenewsw... |
| 10.12.2021 | XORTX Therapeutics Announces Publication of Mt. Sinai Study ... | CALGARY, Alberta, Dec. 10, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or th... | marketscre... |
| 10.12.2021 | XORTX Therapeutics Announces Publication of Mt. Sinai Study ... | CALGARY, Alberta, Dec. 10, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or th... | globenewsw... |
| 09.12.2021 | XORTX Announces Research Coverage Initiated by A.G.P./Allian... | CALGARY, Alberta, Dec. 09, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or th... | globenewsw... |
| 02.12.2021 | XORTX Therapeutics Appoints Altasciences as CRO for Clinical... | CALGARY, Alberta, Dec. 02, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or th... | globenewsw... |
| 23.11.2021 | XORTX Therapeutics Announces Annual and Special Meeting of S... | CALGARY, Alberta, Nov. 23, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or th... | globenewsw... |
| 15.11.2021 | Argus Research Initiates Equity Research Report Coverage on ... | NEW YORK, Nov. 15, 2021 /PRNewswire/ -- Argus Research, an independent investment research firm, has... | marketscre... |
| 15.11.2021 | Argus Research Initiates Equity Research Report Coverage on ... | NEW YORK, Nov. 15, 2021 /PRNewswire/ -- Argus Research, an independent investment research firm, has... | salamancap... |
| 09.11.2021 | XORTX Therapeutics Announces Partial Exercise of Over-Allotm... | CALGARY, Alberta, Nov. 09, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or th... | globenewsw... |
| 04.11.2021 | XORTX Therapeutics Clarifies Halt of Trading in Canada and T... | CALGARY, Alberta, Nov. 04, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or th... | globenewsw... |
| 03.11.2021 | XORTX Therapeutics Receives Final Approval to List on the TS... | CALGARY, Alberta, Nov. 02, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or th... | marketscre... |
| 02.11.2021 | XORTX Therapeutics Receives Final Approval to List on the TS... | CALGARY, Alberta, Nov. 02, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or th... | globenewsw... |
| 16.10.2021 | XORTX Therapeutics Announces Closing of US$12 Million Public... | CALGARY, Alberta, Oct. 15, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or th... | marketscre... |
| 15.10.2021 | XORTX Therapeutics Announces Closing of US$12 Million Public... | CALGARY, Alberta, Oct. 15, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or th... | globenewsw... |
| 14.10.2021 | XORTX Announces Results from Mount Sinai’s COVID-19 Clinical... | CALGARY, Alberta, Oct. 14, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or th... | globenewsw... |
| 14.10.2021 | XORTX to Present at the LD Micro Main Event | CALGARY, Alberta, Oct. 14, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or th... | globenewsw... |
| 14.10.2021 | XORTX to Present at the LD Micro Main Event | CALGARY, Alberta, Oct. 14, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or th... | marketscre... |
| 13.10.2021 | XORTX Therapeutics Announces Pricing of US$12 Million Public... | CALGARY, Alberta, Oct. 13, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or th... | marketscre... |
| 13.10.2021 | XORTX Therapeutics Announces Pricing of US$12 Million Public... | CALGARY, Alberta, Oct. 13, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or th... | globenewsw... |
| 16.03.2021 | XORTX to Present at “Zoom With LD MICRO” | CALGARY, Alberta, March 16, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or t... | globenewsw... |
| 09.03.2021 | XORTX to Present and Participate in the Sachs 14th Annual Eu... | CALGARY, Alberta, March 09, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or t... | globenewsw... |
| 08.03.2021 | XORTX Files New Provisional Patent to Treat and Protect Indi... | ● Compositions and Methods for Enhancing Anti-viral Therapies ●
CALGARY, Alberta, March 08, 2021 (GL... | globenewsw... |
| 02.03.2021 | XORTX Confirms $1 Million in Warrant Exercise Proceeds | CALGARY, Alberta, March 02, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or t... | globenewsw... |
| 01.03.2021 | XORTX Participating in WuXI Healthcare Forum | ● Advancing Partner and Investor Outreach Activities ●
CALGARY, Alberta, March 01, 2021 (GLOBE NEWSW... | globenewsw... |
